title: Response to comment on Malik. Which test for diagnosing early human diabetic neuropathy? Diabetes 2014;63:2206-2208.
authors.affiliation: Division of Medicine, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, Doha, Qatar Centre for Endocrinology and Diabetes, Institute of Human Development, University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K.
authors.forename: Ioannis N
authors.initials: IN
authors.lastname: Petropoulos
authors.affiliation: Centre for Endocrinology and Diabetes, Institute of Human Development, University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K.
authors.forename: Mitra
authors.initials: M
authors.lastname: Tavakoli
authors.affiliation: Department of Clinical Neurophysiology, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, U.K.
authors.forename: Andrew
authors.initials: A
authors.lastname: Marshall
authors.affiliation: Division of Medicine, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, Doha, Qatar Centre for Endocrinology and Diabetes, Institute of Human Development, University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K. ram2045@qatar-med.cornell.edu rayaz.a.malik@manchester.ac.uk.
authors.forename: Rayaz A
authors.initials: RA
authors.lastname: Malik
mesh_terms: D003315:Cornea / Q000473:pathology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003929:Diabetic Neuropathies / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D009412:Nerve Fibers / Q000473:pathology*; D012867:Skin / Q000473:pathology*